Thank you to our Sponsors:
Global Health in A Changed Era:
The View from Europe
The PQMD Global Health Policy Forum is a long-standing annual event featuring conversations with global health experts and leaders designed to inform public debate; address contemporary health policy approaches; and explore the most pressing challenges and innovative trends shaping development and the policies that impact them. This event is designed to share real-world perspectives on the practical implications of promoting and accelerating greater access to healthcare in underserved communities and disaster-affected areas through excellence in medical products, services, and device donations.
This year’s event will unite more than 100 global health leaders from over 70 organizations, speakers and panelists from around the world to lead in-depth discussions. Being in Paris will provide the direct opportunity for European voices and perspectives to be clearer at a time when the region’s imperatives and interventions are changing rapidly. The program will consist of an Executive Forum followed by two days of compelling sessions that focus on key aspects of this year’s theme: European Leadership in the Global Health Agenda.
This convening aims to build cross-sectoral knowledge to meet the global public health challenges of today and the opportunities of tomorrow.
Please note: All times are Central European Time (CET)
EUROPEAN GLOBAL HEALTH STRATEGY: HOW WILL WE ACHIEVE BETTER HEALTH FOR ALL?
The European Union is committed to pursuing better health for all. Together, we will explore how the European and French health strategy is designed for this achievement, how it will support and contribute to the response to global health emergencies and how it will strengthen health systems. We will consider how trends in financing, public-private partnerships and philanthropy will advance this agenda and explore how climate change, technology, access and equity will impact our programming and priorities.
The outcome is expected to be:
- an expectation that we will work together to translate policy into practice to address the global health strategies of the future;
- inspire public-private partnerships that will be productive collaborations around the most critical issues;
- increase focus on preparedness and resilience to confront global health and humanitarian emergencies.
TRENDS IN FINANCING EUROPE’S HEALTH AGENDA
Financing and philanthropy is integral to advancing Europe’s health priorities. The aim is to better understand the prosperity, social investing and impact drivers that fuel philanthropy in Europe and catalyze innovation and transformative financing.
Sessions will focus on:
- Re-energizing European philanthropy and exploring innovative public-private partnerships.
- Learning about blended financing models that can drive transformational change.
- Exploring European ESG accountability measures and how global organizations can prepare for a changing reporting landscape.
WELCOME: FOUNDATION S – THE SANOFI COLLECTIVE, TULIPE, PARTNERSHIP FOR QUALITY MEDICAL DONATIONS
KEYNOTE: EUROPEAN PHILANTHROPY LANDSCAPE
PANEL: RE-ENERGIZING EUROPEAN PHILANTHROPY AND EXPLORING INNOVATIVE PUBLIC PRIVATE PARTNERS
This panel will explore the intersection of finance and purpose. The aim is to better understand the prosperity, social investing and the impact drivers that fuel philanthropy in Europe and catalyze innovation and transformative financing. We will explore how European philanthropy differs from American philanthropy. We will look at how European foundations have focused on catalyzing and spreading innovation and on transformative financing. Panelists will discuss the ways that European foundations often work closely with national governments and with the European Commission to achieve shared goals.
PANEL: BLENDED FINANCE TO DRIVE TRANSFORMATIONAL CHANGE
As overseas development assistance stalls or is even cut, there is a new focus on innovative mechanisms, accelerated by the increased involvement of international and regional development finance institutions. Many of these mechanisms involve contingent financing, payment by results and financial instruments such as sustainable development bonds. This implies fewer pilots and small-scale projects and more investments at national or regional level with more reliance on non-donor financing. Panelists will explore the implications for humanitarian organizations, pharmaceutical companies and others and ways that task-specific partnerships are likely to evolve.
PANEL: EXPLORING EUROPEAN ESG ACCOUNTABILITY AND HOW GLOBAL ORGANIZATIONS CAN PREPARE FOR A CHANGING REPORTING LANDSCAPE
Stakeholders around the world continue to call for increased transparency surrounding a companies’ environmental, social, and governance measures led primarily by agencies and organizations in Europe and the U.S. In 2022, the European Council and European Parliament took steps to ensure that the European Union (EU) ESG regulations adopted EU ESG reporting requirements designed to drive changes in company behavior and bring sustainability reporting on par with financial reporting over time. This panel discussion will help illuminate the EU reporting disclosure outlook and how global organizations can help better understand and prepare for a changing reporting landscape.
Exploring the economic, political and social insecurity in the region and implications for health systems in surrounding and supporting countries.
TRENDS IN CLIMATE CHANGE, ACCESS & SUSTAINABILITY
Climate change, health access and equity and transformational technology are key elements to the global health outlook. How do we adapt and invest in promoting ambitious global action and building greater resilience?
Sessions will focus on:
- The impact of climate change on humanitarian response and global health more broadly, to better determine how we can adapt and invest in creating more sustainable communities.
- Challenges in increasing equity and access to health care and how we can build on efforts to address the underlying social determinants of health.
- In the face of these formidable trends, the design of our global institutions and efforts to provide quality health care for all, what can we do together moving forward?
KEYNOTE: IS THE CURRENT HUMANITARIAN ARCHITECTURE TRULY FIT FOR PURPOSE FOR THE CRISIS OF CLIMATE CHANGE?
PANEL: CLIMATE CHANGE: THE RISKS TO HUMAN HEALTH
The impact of climate change is already apparent in the increasing severity of climate events globally, from increased flooding to unprecedented heatwaves, to outbreaks of emerging infectious diseases. This session will explore the impact of climate change on the humanitarian response sector and global health more broadly, to better determine how we can mitigate the growing impact and invest to create more resilient communities.
CLIMATE CHANGE: SOLUTION LAB
KEYNOTE: WILL UNIVERSAL ACCESS EVER BE TRULY UNIVERSAL?
PANEL: ACCESS, EQUITY, & ECONOMIC DEVELOPMENT
This panel aims to illuminate the intersection of access, equity & economic development. Access and Equity are two key concepts within a broad social justice framework that seek to tackle economic disparity and income equality. The panelists will discuss how to make the aspiration of universal access truly universal.
NGO CEO ROUNDTABLE:
Three things European governments can do to support NGOs and Community response during this unprecedented level of humanitarian crises.
LOGISTICS & HOTEL INFORMATION
- Executive Forum (April 25) – Musee Economie Paris | 1 Pl. du Général Catroux, 75017 Paris
- April 26 & 27 – Sanofi Gentilly Facility | 82 Av. Raspail, 94250 Gentilly, France
Novotel Paris 14 Porte d’Orléans | 15-17-21 boulevard Romain Rolland, 75014 Paris France | Tel: +33 (1) 41 17 26 00
We have arranged for a discounted block of rooms exclusively for event attendees. Discounted rooms are limited and are available on a first-come, first-served basis. You can book at our special rate using this link and the preferential code: PQMD. You can also call the hotel directly and book with the same preferential code.
Click here for detailed instructions to navigate the hotel reservation system.
The hotel is approximately a 20-minute taxi ride from Orly and an hour from Charles de Gaulle. It is also approximately a 5-minute walk to the Metro, which is about a 20-minute ride to the city center.
Please note, once a room is booked there is no refund on the booking unless approved by PQMD as we are responsible for a minimum number of rooms.
The dress code during the meeting is business attire.
MEET OUR SPEAKERS
Select speakers include:
- Tilly Alcayna, Sr Technical Advisor, Cholera Early Warning, Red Cross Red Crescent Climate Ctr
- Jodi Allison, Senior Vice President, Global Giving and Innovation, MAP International
- Ambassador Anne Claire Amprou, Global Health Ambassador, Ministry of Europe and Foreign Affairs, France
- Bertrand Badré, Managing Partner and Founder, BlueOrange Sustainable Capital
- Prof. Agnès Binagwaho, Professor and Retired Vice Chancellor of the University of Global Health Equity – Rwanda
- Dr. François Bompart, Chair, Access Committee, Drugs for Neglected Diseases initiative (DNDi)
- Patrice Carayon, President, Tulipe; General Director, Chiesi France
- Sean Carroll, President and CEO, Anera; CEO, Anera Ventures
- Mark Chataway, Managing Partner, Hyderus Finn Partners
- Paul Knox Clarke, Principal, ADAPT Initiative
- Audrey Derveloy, President & Country Lead, Sanofi France
- Per Falk, CEO, Ferring Pharma
- Allison Goldberg, Head of Global Giving, Merck
- Douglas Jackson, President & CEO, Project C.U.R.E.
- Tim Kattwinkel, VP Supply Chain EMEA, Henry Schein
- Sylvain Lambert, Partner, Plateforme ESG/Sustainability Leader, PWC France
- Vanina Laurent-Ledru, Director General, Foundation S- The Sanofi Collective
- Rt Hon David Miliband, President and CEO, International Rescue Committee
- Benoît Miribel, Secretary General, One Sustainable Health for All Foundation
- Bathylle Missika, Head – Networks, Partnerships and Gender Division, OECD Development Centre
- Adele Paterson, CEO, International Health Partners
- Onno Ruhl, General Manager, Aga Khan Agency for Habitat
- Matthew Swift, Co-Founder and CEO, Concordia
- Chris Skopec, Executive Vice President, Project HOPE; Chair, PQMD
- Frank Welvaert, Vice President Global Strategy – Global Community Impact, J&J
- Kelly Willis, Healthy Futures, Malaria No More
- Karen Wilson, Global Impact Leader, Sorenson Impact
- Prashant Yadav, Affiliate Professor of Technology and Operations Management, INSEAD
- Peter Ziese, Head of Medical Innovation and Strategy and SVP, Philips Medical Systems
Jodi Allison, Senior Vice President, Global Giving and Innovation, MAP International
Jodi Allison joined MAP International, a Georgia based non-profit that provides life-changing medicine and health supplies to people in need, 24 years ago. She has always worked in the Corporate Relations division at MAP, being promoted to Director of Corporate Relations in 2010 and Vice President, Global Giving in 2014. She is now Senior Vice President of Global Giving and Innovation. In this role, she serves MAP’s mission of providing essential medicine and health supplies to the world’s most vulnerable communities. She is responsible for leadership and management of the Global Giving team, securing donated medicines, health supplies and cash gifts and developing strategic and annual operating plans. She is also responsible for the strategy and implementation of MAP’s innovation initiatives. She attended the Georgia Institute of Technology and Middle Tennessee State University to receive her International Affairs degree with minors in Public Relations and History. When she is not saving the world, you will find her on the beach near her home in Tampa, FL, with her two college-aged boys.
Bertrand Badré, Founder and Managing Partner, Blue like an Orange Sustainable Capital
Bertrand Badré is Managing Director and Founder of Blue like an Orange Sustainable Capital. Previously, Bertrand was Managing Director of the World Bank and World Bank Group Chief Financial Officer. Prior to this, Bertrand was group Chief Financial Officer at Société Générale and Crédit Agricole and served as a member of President Jacques Chirac’s diplomatic team as his deputy personal representative for Africa. He spent seven years at Lazard in New York, London and latterly in Paris as Managing Director where he co-led the restructuring of Eurotunnel. He started his career in Paris as an Inspector, then Deputy Head, of the auditing service of the French Ministry of Finance. Bertrand currently serves on the board of Canadian Fintech Wealth Simple and he is a non-Executive Director at Getlink (Groupe Eurotunnel). Bertrand wrote a book “Can Finance Save the World?” prefaced by Emmanuel Macron and Gordon Brown and translated in multiple languages. Recently he wrote the book « Voulons-nous (sérieusement) changer le monde ? », prefaced by Erik Orsenna. Published articles include “From Billions to Trillons: MDBs contributions to financing for development”, the first joint report from the IMF, EIB, Regional Multilateral Development Banks and the World Bank Group. Bertrand is a graduate of ENA, SciencesPo and HEC. He is a regular speaker and teacher at these and other institutions including Georgetown, Johns Hopkins, Princeton and Oxford.
Prof. Agnes Binagwaho, Professor and Retired Vice Chancellor of the University of Global Health Equity – Rwanda
Professor Agnes Binagwaho, MD, M(Ped), PHD currently resides in Rwanda. She is the retired Vice Chancellor and co-founder of the University of Global Health Equity (UGHE) (in 2015), an initiative of Partners In Health based in Rwanda which focuses on changing how health care is delivered around the world by training global health professionals who strive to deliver more equitable, quality health services for all. She is a Rwandan pediatrician who returned to Rwanda in 1996, two years after the 1994 Genocide Against the Tutsi. Previously, she has provided clinical care in the public sector and has served the Rwandan health sector (1996-2016) in high-level government positions, first as the Executive Secretary of Rwanda’s National AIDS Control Commission, then as Permanent Secretary of the Ministry of Health, and lastly as Minister of Health for five years. She is a Professor of Pediatrics at UGHE, a Senior Lecturer in the Department of Global Health and Social Medicine at Harvard Medical School, and an Adjunct Clinical Professor of Pediatrics at Dartmouth’s Geisel School of Medicine. She is member of multiple editorial, advisory and directors’ boards, including the Think20 (T20), the Rockefeller Foundation, the African Europe Foundation and the African Union Commission on African COVID-19 Response. Professor Binagwaho is a member of the U.S. National Academy of Medicine and the World Academy of Sciences, and a fellow of the African Academy of Sciences. She is an Emerson Elder and has published over 250 peer-reviewed articles and was named among the 100 Most Influential African Women for 2020 and 2021.
Dr. François Bompart, Chair of the DNDi Access Committee, Drugs for Neglected Diseases initiative
François Bompart, MD is, since 2021, the Chair of the Access Committee of the Drugs for Neglected Diseases initiative (DNDi), a non-profit organisation based in Geneva (Switzerland).
His has worked for over 25 years in anti-infective medicines and vaccines, with a focus on emerging and developing countries, mostly within the Sanofi pharmaceutical group before joining DNDi in 2018. His main fields of interest are related with access to care in resource-limited countries, as well as ethical issues in clinical research for vulnerable populations. He is, since 2022, a member of the Ethics Committee of the French National Institute for Health and Medical Research (Inserm).
François Bompart received his MD from the University of Angers (France) and trained in Clinical Pharmacology at University College London (UK) and Hôpital Cochin in Paris (France).
Patrice Carayon, President, Chiesi France and President, Tulipe Association
A graduate of ESCP Europe and the Indian Institute of Management in Ahmedabad, Patrice Carayon has 30 years of experience in the healthcare sector. His career path has been marked by the various functions he has held in different pharmaceutical laboratories: Regional Director, Commercial Director and Business Unit Director (or Division Director), which allowed him to develop a macro vision of this very specific environment.
President of Chiesi France since 2016 and of NHCO-Nutrition since 2018, Patrice Carayon also holds the mandate of President of the Tulipe Association since 2020. A true interface between industry and associations, Tulipe brings together donations from health companies to respond, urgently, to the needs of populations in distress during global health crises.
Sean Carroll, President and CEO, Anera; CEO, Anera Ventures
Sean Carroll is Anera’s president and chief executive officer and the CEO of Anera Ventures, LLC. Anera delivers to the most vulnerable in Gaza, the West Bank, Lebanon, Jordan, and Syria nearly $100 million worth of medicines and medical supplies annually, donated mostly by PQMD members. Sean also leads Anera’s long-term human and community development programs in resilience and sustainability through water, renewable energy and food security initiatives; in education, through early childhood development, vocational training and upskilling; and in health and livelihoods. With Anera Ventures, he aims to scale up impact working with impact investors.
Before joining Anera, Sean worked in several international development and policy roles in Washington, DC, Europe and the Middle East, including at USAID in the Obama-Biden Administration, the US Congress, the UN World Food Programme and Creative Associates International. He served as chief of staff and COO at USAID, with 9,500 staff, 84 missions around the world and a $1.7 billion operating budget. Sean also served for six years as director of programs for the Club of Madrid, a leadership alliance that includes 106 former presidents and prime ministers.
He serves on the boards of PQMD and Creative Frontiers; and is an advisor to the Club of Madrid and TechChange.
Allison Goldberg, President, Merck Foundation
Corporate leader and public health & research expert with experience designing and launching a social impact division and corporate foundation, managing a multi-million-dollar budget, growing program & research portfolios and staff, and surpassing key performance and impact indicators. Strong executive presence with proven capacity to manage corporate and Board relationships. Deep experience navigating complex stakeholder environments and engaging with internal and external partners, across the corporate, academic, governmental, and non-governmental sectors, in the
U.S. and internationally. Author and presenter with experience articulating the societal value of business and corporate foundations, public-private partnerships, and models to address complex societal challenges, including the social determinants of health, reducing health disparities, health systems strengthening, strategies to improve vaccine uptake, and communicable and non-communicable disease prevention. Previous teaching experience at Columbia University.
Paul Knox Clarke, Principal, ADAPT Initiative
Paul Knox Clarke is Principal of the ADAPT initiative on climate change and humanitarian action, and an expert in the humanitarian consequences of climate change. He and his team advise a wide range or intergovernmental and non-governmental organisations on how to respond to the climate crisis. He also regularly speaks and writes on the issue. Paul has previously worked for WFP and SC (UK) as a humanitarian practitioner in a variety of conflict environments; as CEO for an organisational change consultancy; and as Director of research for the ALNAP network.
Vanina Laurent-Ledru, Director General, Foundation S- The Sanofi Collective
Vanina is on a mission to create healthier futures for generations to come. As Director General of Foundation S – The Sanofi Collective, she does so by catalyzing public health initiatives, leveraging Sanofi’s philanthropy, and driving its medicine donations strategy. She has been working in the public (Gavi) and private sector (at SPMSD, Merck and Sanofi) to bring health innovations closer to patients and vulnerable populations.
She is a staunch gender equity advocate and founded several women empowerement networks in France and in the US and is a past Board member of CSR Europe.
Rt Hon David Miliband, President and CEO, International Rescue Committee
David Miliband is the President and CEO of the International Rescue Committee. He oversees the agency’s operations in 40 crisis-effect countries and its refugee resettlement and assistance programs throughout Europe and the Americas. The IRC’s mission is to help the world’s most vulnerable people, whose lives and livelihoods have been shattered by conflict and disaster, including the climate crisis, to survive, recover, and regain control of their future. In 2021 alone, the IRC served more than 31.5M people in countries affected by crisis, more than 2.7M people with water sources, and more than 1.3M people with malnutrition prevention assistance.
Prior to joining IRC, David had a distinguished political career in the United Kingdom. From 2007 to 2010, he served as the 74th Secretary of State for Foreign and Commonwealth Affairs, representing the United Kingdom throughout the world. His accomplishments have earned him a reputation, in former President Bill Clinton’s words, as “one of the ablest, most creative public servants of our time.” In 2016 David was named one of the World’s Greatest Leaders by Fortune Magazine and in 2018 he was inducted into the American Academy of Arts and Sciences.
David is also the author of the book, Rescue: Refugees and the Political Crisis of Our Time. As the son of refugees, David brings a personal commitment to the IRC’s work and to the premise of the book: that we can rescue the dignity and hopes of refugees and displaced people, and if we help them, in the process we will rescue our own values.
Benoît Miribel, Secretary General, One Sustainable Health for All Foundation
Benoît Miribel is the Secretary General of the One Sustainable Health for All Foundation launched during the COVID 2020 lockdown and which coordinates the OSH Forum and the One Europe for Global Health coalition (OEGH).
He is a member of the French Economy, Social and Environmental Council (CESE).
He has chaired the French Foundations Center (CFF) (2015-2022).
Before, he has joined Institut Merieux from April 2019 to June 2020, as Director for Global Health. He has been, from January 2007 to March 2019, the Director General of Fondation Mérieux, an organization dedicated to the fight against infectious diseases in developing countries.
He has been the Honorary Chairman of Action against Hunger (ACF) since June 2013, an NGO that he chaired from 2010 to 2013 and managed as director general from 2003 to 2006.
He was a board member of the European Foundation Center (EFC) from 2013 to 2016 and a board member of VOICE, the European Network of Humanitarian NGOs (2003/2006).
He is the co-founder of the bilingual journal “Humanitarian Alternatives” and the chairman of Earthwake an NGO dedicate to recycling plastic bags. He is a member of the Friendship board (Bangladesh).
He was a member of the High Council for International Cooperation (HCCI), a member of the Commission’s White Paper of the Ministry of Foreign Affairs (2008), and of the National Commission on Human Rights (1998-2001 and 2011-2013).
Matthew Swift, Co-Founder and CEO, Concordia
Matthew Swift is the Co-Founder & CEO of Concordia. Since its inception in 2011, Matthew has grown Concordia into the leading nonpartisan global affairs forum dedicated to forming cross-sector partnerships that address the greatest challenges and opportunities of our time. Hosting summits in New York City, Miami, Bogotá, Athens, Madrid, and London, Concordia actively bridges the divide between the business, government, and nonprofit communities.
Today, the Concordia Annual Summit in New York City is the largest and most inclusive nonpartisan forum alongside the UN General Assembly. Matthew has interviewed preeminent world figures such as Former U.S. Presidents George W. Bush and Bill Clinton, Former U.S. Secretary of Defense Donald Rumsfeld, Former U.S. Secretary of Transportation Elaine Chao, Former Administrator of USAID Ambassador Mark Green, Former Homeland Security Advisor Frances Townsend, Former President of Colombia Álvaro Uribe, Carlyle Group Co-Founder David Rubenstein, former senior White House advisor Ivanka Trump, and Eurasia Group’s President & Founder Dr. Ian Bremmer, among others.
Matthew is the host and interviewer of The Swift Hour, a series of short video interviews with prominent government, non-profit, and business leaders like former Secretary of Transportation, Rodney Slater; U.S. Surgeon General Dr. Vivek Murthy; Jared Kushner; retired General Wesley Clark; Dr. Susan Harvey; and more.
Matthew’s career spans the public and private sectors. He is Founder & Managing Partner at Montfort Advisory, a public relations and business development firm providing bespoke executive advisory services led by excellence and guided by a commitment to longevity and social responsibility.
Prior to founding Concordia, Matthew worked in the media industry, holding positions within News Corporation and its subsidiaries, Fox News Channel, British Sky Broadcasting, and the New York Post.
Frank Welvaert, Vice President, Global Strategy, Global Community Impact, Johnson & Johnson
Currently Frank leads Global Strategy for Global Community Impact, with teams in Europe, Middle East and Africa, North America, Latin America, and Asia Pacific. From 1997 till 2007 he had different roles for Johnson & Johnson in the context of CSR and sustainability in the EMEA region. From 2007 till 2017, he served as Managing Director of the Johnson & Johnson Foundation Scotland (EMEA) and between 2014 and 2016 led the impact investment set up within the corporation. Currently his main focus is on the healthcare workforce as a key contributor to more equitable health systems and improved patient care.
Prior to joining Johnson & Johnson in 1997, he was Senior Advisor at the King Baudouin Foundation (Belgium) and worked on the setup and development of the King Baudouin Foundation U.S. in 1996 – 1997. Until 2015 Frank was a Member of the Supervisory Board of the Academy for Business in Society, an international organisation of business schools and universities based in Brussels. From 2002 until 2008 he was Chairman of the Board of CSR Europe, the European business network on corporate social responsibility. In 2016, he was a member of the Advisory Panel for the UK Government on Mission-led Business development.
He has a M.A. in Modern History at Ghent University (Belgium). He is a Member of the Johnson & Johnson Foundation Scotland and the Institute of Directors (UK).
Karen Wilson, Founder & CEO, GV Partners
Karen is a Senior Advisor on sustainability, ESG and impact. She has worked across the public and private sectors, including over 12 years leading work at the OECD on financing sustainable development, impact investment and impact measurement, as well as co-leading the launch of the Impact Management Platform. She is Chair of the Supervisory Board of the Impact Linked Finance Fund and a board member of the European Venture Philanthropy Association (EVPA), where she Chair the Nominations, Successions and Remuneration Committee. She was a member of the G7 Impact Taskforce Working Group on Impact Reporting, Integrity and Transparency and served on the Global Impact Investment Steering Group (GSG) Board of Trustees Strategy Committee. She is an Associate Fellow at Said Business School at Oxford University and a Senior Advisor and Sustainability/ESG Lead at the Institute of Strategy at the Stockholm School of Economics in Riga, where she also is a Visiting Lecturer. In 2022, she was selected by the Sorenson Impact Center as a Global Impact Leader.